Today, we dive a bit deeper into Cancer by exploring a few key news on various Cancer types and stories. I was personally motivated to write about Cancer as the stories that I have read moved me so much that I felt like I had to get this done before I sleep. Without any further ado, let’s look at what is happening in the space today.
Cancer news – 13 August 2017
- Too Few Patients, Too Many Trials
In a recent The New York Times article, Gina Kolata explores what it means when pharmaceutical companies try to come up with proprietary drugs but not truly novel from a scientific perspective. In a bid to capitalize on drugs discovery, researchers have instead focus on picking the right subjects for clinical trials (which is ridiculous in some instances). An alarming statistic highlighted was the fact that more than 1,000 immunotherapy trials are underway! Imagine the costs of so many different people doing the same things just to profit off the market. Classic vulture behaviors.
This article is spectacular and definitely worth a read. This article also enforces why we started CuraHOPE in the first place.
- Ex Emmerdale Star, Leah Bracknell’s Latest Cancer Treatment Has Failed, But Her Fight Continues
According to The Sun, Leah was diagnosed with terminal lung cancer late last year. However, the drug she was taking failed to work after March this year and her partner mentioned that she is now on alternative treatments. She remains strong and inspirational in the face of Cancer. There is still too much we do not know about Cancer and why it happens, yet there are still studies focusing on select research and publication of papers as their objectives. Her story is one which remains us that no one is truly immune to unforeseen diseases, and there is a need for mankind to fight together.
- Drugmaker BTG Trying To Come Up With Devices To Treat Cancer
As reported in Telegraph, FTSE listed drug company, BTG is trying to come up with new medical devices to deliver immune system boosting drugs directly (through special needles, catheters and probes) to cancer affected parts of the body. They are targeting this US$8 billion a year global immuno-oncology drugs market, which is expected to reach US$50 billion. The global healthcare market is extremely lucrative, but very distorted and cumbersome, and patients do not live long enough to see true cures.
- Cancer Is An Expensive Disease
We all know treatment for Cancer is expensive, but how expensive is it? Very expensive, even with insurance. An article on MedicineNet explores the cost of treatment for cancer even with insurance, and the average expense is around US$600. This basically reinforces why true cures for incurable and chronic diseases such as Cancer should exist.
Cancer is an expensive and lucrative disease. The research direction is all over the place, with shareholders and investors not knowing significant information to make truly informed decisions. We will continue to attempt to bring true knowledge and make it simple for everyone to consume, and someday, work towards true cures for all incurable diseases and conditions in the world.